832 BM2
Pill imprint 832 BM2 has been identified as Benztropine mesylate 2 mg.
Benztropine is used in the treatment of parkinson's disease; extrapyramidal reaction and belongs to the drug class anticholinergic antiparkinson agents. FDA has not classified the drug for risk during pregnancy.
Benztropine 2 mg is not subject to the Controlled Substances Act.
See also related documents.
Benztropine mesylate Images
- Imprint:
-
832 BM2
- Strength:
- 2 mg
- Color:
- White
- Size:
- 7.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- croscarmellose sodium
lactose anhydrous
magnesium stearate
povidone
- Drug Class:
- Anticholinergic antiparkinson agents
- Pregnancy Category:
- N - Not yet classified
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Upsher-Smith Laboratories, Inc
- National Drug Code (NDC):
- 00832-1082
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0222 | UDL Laboratories Inc |
| 00904-1057 | Major Pharmaceuticals |
| 63874-0565 | Altura Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Benztropine Mesylate resources
- Benztropine (Wolters Kluwer)
- Benztropine Tablets (Wolters Kluwer)
- benztropine (Cerner Multum)
- benztropine (Micromedex) - Includes Dosage Information
- benztropine Injection (Micromedex) - Includes Dosage Information
- Benztropine Mesylate (AHFS DI)
- Benztropine (FDA)
- Benztropine Injection (FDA)
- Benztropine Mesylate (Wolters Kluwer)
Search Again
